top of page
Search

Affirm (AFRM)

Writer: Abacus Research
Abacus Research
Mar 12, 2025
1 min read

Share gainer with a proven business model? Or consumer stock right in front of a credit cycle?

Yes, there is the potential for a significant top down impact on all credit plays, however at $46 AFRM is pricing in numbers ~30% below the street by our ests.


We like the long term positioning as we are convinced of the structural element of growth and BNPL taking share.

  • The business model is proven, with BNPL and AI based online lenders showing amazing growth in the 30%-100% range.

  • The share gaining aspect of BNPL and its oligopoly market structure is highly attractive and will take years, which is why we would be interested in the stock.


Unless the macro implodes, downside on AFRM seems low to us.


Potential Upside:     $64 (+39%)

Sensible Downside: $40(-14%)


 
 
 

Recent Posts

See All
GOOGL, AMZN: Plays on inference and bundling

We see the power moving back towards the Hyperscalers, and find the combination of less risk, high growth and reasonable valuations to be compelling. AMZN: sensible upside to $305 (+20%) SOTP model an

 
 
 
RYAN / Insurance Cycle

Ryan (RYAN) is a typical hard market beneficiary, that is going through an organic growth reset. Are we there yet in terms of the reset- probably not. Timing the bottom of a cyclical market is hard. N

 
 
 
Nebius & DigitalOcean: Inference Efficiency

(NBIS, DOCN) 1. The Core AI Thesis At the core of all AI theses there are two beliefs: Demand for intelligence is ~infinite — this still seems to be true, at leas there is no data to the contrary. Com

 
 
 

Comments

bottom of page